Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Calcimedica Ord Shs (CALC)  
$0.44 0.00 (0.00%) as of 4:30 Fri 3/17


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 5,660,000
Market Cap: 2.49(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4404 - $0.4404
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Graybug Vision is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. Co.'s product candidate, GB-102, is an intravitreal injection of a microparticle depot formulation of sunitinib, a potent inhibitor of neovascular growth and permeability, which are causes of retinal disease. Co.'s second product candidate, GB-401, is an intravitreally administered, proprietary implant formulation containing a prodrug of a beta-adrenergic receptor inhibitor developed to provide a controlled release of the active drug to maintain reduced intraocular pressure, for six months or longer after a single injection.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 77,466 93,566 420,520 1,985,364
Total Buy Value $205,670 $234,155 $1,454,953 $7,170,886
Total People Bought 6 6 8 8
Total Buy Transactions 23 27 35 57
Total Shares Sold 1,000 1,000 1,000 1,000
Total Sell Value $3,650 $3,650 $3,650 $3,650
Total People Sold 1 1 1 1
Total Sell Transactions 1 1 1 1
End Date 2025-06-19 2025-03-18 2024-09-17 2023-09-18

   
Records found: 179
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-09-15 4 B $2.68 $9,105 I/I 3,400 81,650 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-09-12 4 B $3.12 $15,600 I/I 5,000 78,250 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-09-09 4 B $3.15 $7,378 I/I 2,343 73,250 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-08-29 4 B $2.74 $2,192 I/I 800 70,907 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-08-28 4 B $2.86 $26,340 I/I 9,200 70,107 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-08-21 4 B $2.79 $9,797 I/I 3,508 60,907 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-08-20 4 OE $1.53 $22,950 D/D 15,000 179,706     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-08-20 4 B $2.72 $5,440 I/I 2,000 57,399 0.01     -
   Hebbar Sudarshan Chief Medical Officer   •       –      –    2025-08-19 4 B $2.82 $26,962 D/D 9,563 61,539 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-08-19 4 B $2.79 $2,790 I/I 1,000 55,399 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-08-15 4 B $2.90 $14,709 I/I 5,076 54,399 0.01     -
   Hebbar Sudarshan Chief Medical Officer   •       –      –    2025-08-15 4 B $2.79 $12,267 D/D 4,392 51,976 0.01     -
   Hebbar Sudarshan Chief Medical Officer   •       –      –    2025-08-14 4 B $2.59 $4,095 D/D 1,584 47,584 0.01     -
   Stauderman Kenneth A. Chief Scientific Officer   •       –      –    2025-07-28 4 B $3.96 $3,960 D/D 1,000 12,944 0.01     -
   Stauderman Kenneth A. Chief Scientific Officer   •       –      –    2025-07-25 4 S $3.65 $3,650 I/I (1,000) 0     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-07-22 4 B $3.78 $5,663 I/I 1,500 49,323 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-07-21 4 B $3.37 $5,055 I/I 1,500 47,823 0.01     -
   Leheny A. Rachel CHIEF EXECUTIVE OFFICER   •       •       •   2025-07-21 4 B $3.40 $3,400 I/I 1,000 3,500 0.01     -
   Wilson Robert N   –       •      –    2025-07-18 4 B $2.87 $12,915 D/D 4,500 422,029 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-07-18 4 B $2.88 $5,760 I/I 2,000 46,323 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-07-14 4 B $2.43 $15,810 I/I 6,500 44,323 0.01     -
   Leheny A. Rachel CHIEF EXECUTIVE OFFICER   •       •       •   2025-07-14 4 B $2.47 $6,175 I/I 2,500 2,500 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-07-09 4 B $1.60 $8,024 I/I 5,000 37,823 0.01     -
   Stauderman Kenneth A. Chief Scientific Officer   •       –      –    2025-07-01 4 B $1.85 $1,850 I/I 1,000 1,000 0.01     -
   Roberts Eric W CHIEF BUSINESS OFFICER   •       •       •   2025-06-26 4 B $1.44 $6,483 I/I 4,500 32,823 0.01     -
  179 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us